References
- Boonpongmanee S, Fleischer DE, Pezzullo JC, The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc 2004;59:788-794.
- Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-727.
- Wilcox CM, Clark WS. Causes and outcome of upper and lower gastrointestinal bleeding: the Grady Hospital experience. South Med J 1999;92:44-50.
- Yavorski RT, Wong RK, Maydonovitch C, Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 1995;90:568-573.
- Vreeburg EM, Snel P, de Bruijne JW, Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997;92:236-243.
- Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population based study. Am J Gastroenterol 1997;92:419-424.
- Manning-Dimmitt LL, Dimmitt SG, Wilson GR. Diagnosis of gastrointestinal bleeding in adults. Am Fam Physician 2005;71: 1529-1537.
- American Society for Gastrointestinal Endoscopy. AGSE guideline: the role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc 2004;60:497-504.
- Rockall TA, Logan RF, Devlin HB, Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-321
- Lee JG. The role of endoscopy in triage of patients with upper-GI bleeding. Clin Update 2005;12:1-4.
- Goldfarb NI, Phillips A, Conn M, Economic and health outcomes of capsule endoscopy: opportunities for improved management of the diagnostic process for obscure gastrointestinal bleeding. Disease Manage 2002;5:123-135.
- Solomon DH, Glynn RJ, Bohn RLR, The hidden cost of nonselective nonsteroidal anti-inflammatory drugs in older patients. J Rheumatol 2003;30:792-798.
- Charlson ME, Pompei P, Ales KL, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
- Leontiadis GI, Sreedharan A, Dorward S, Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess 2007;11:1-164.
- Chan FK, Hung LC, Suen BY, Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 2002;347:2104-2110.
- Lai KC, Chu KM, Hui WM, Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Am J Med 2005;118:127-128.
- Jensen DM, Cheng S, Kovacs TO, A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med 1994;330:382-386.
- Wolde S, Dijkmans BA, Janssen M, High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs. Aliment Pharmacol Ther 1996;10:347-351.
- Massó González EL, García Rodríguez LA. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study. Aliment Pharmacol Ther 2008;28:629-637.
- Rahme E, Barkun AN, Toubouti Y, Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib? Arthritis Rheum 2007;57:748-755.
- Enns RA, Gagnon YM, Rioux KP, Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2003;17:225-233